White House Press Secretary Sean Spicer today said that the Trump administration may engage in “greater” efforts to enforce federal anti-marijuana laws in jurisdictions that have legalized and regulated its adult use.
In response to a question regarding how the administration intends to address statewide marijuana legalization laws, Spicer indicated that the administration views the regulation of marijuana for medical purposes as distinct from laws governing its adult use.
He said: “I’ve said before that the President understands the pain and suffering that many people go through who are facing, especially, terminal diseases and the comfort that some of these drugs, including medical marijuana, can bring to them.” He then added, But “there’s a big difference between that and recreational marijuana. I think that when you see something like the opioid addiction crisis blossoming in so many states around this country, the last thing we should be doing is encouraging people.”
On the latter topic, he concluded, “I do believe you will see greater enforcement” of anti-marijuana laws from the Department of Justice.
While campaigning, President Trump voiced support for the authority of individual states to impose regulatory policies specific to the use and dispensing of medical cannabis, but was somewhat less clear with regard to whether he believed that state lawmakers ought to be able to regulate the adult use of cannabis absent federal interference. For instance, he stated that changes in the law in Colorado — one of eight states to legalize the adult use of marijuana — had led to “some big problems.”
Senator Jeff Sessions, now US Attorney General, has been historically critical of marijuana policy reforms, stating: “[M]arijuana is not the kind of thing that ought to be legalized. … [I]t’s in fact a very real danger.” He also opined, “Good people don’t smoke marijuana,” and previously endorsed legislation to execute marijuana traffickers.
During his testimony before members of the Senate Judiciary Committee in January, Sessions indicated that as US Attorney General he may take a more aggressive approach than did the Obama administration with regard to states that have enacted recreational use laws.
Commenting on Spicer’s comments, NORML Deputy Director Paul Armentano said: “The press secretary’s comments are hardly surprising and they are similar to comments made by the new US Attorney General Jeff Sessions during his vetting process when he made clear that any use of marijuana remains against federal law and that ‘it is not the Attorney General’s job to decide what laws to enforce.’
“Ultimately, those who reside in jurisdictions that have legalized and regulated cannabis under state law will only truly be safe from the threat of federal prosecution when and if members of Congress elect to amend federal marijuana laws in a manner that comports with majority public opinion and the plant’s rapidly changing legal and cultural status. Certainly, Congressional passage of HR 975, ‘The Respect State Marijuana Laws Act,’ and/or re-authorization of the Rohrabacher-Blumenauer amendment would be steps in the right direction to protect patients and others in legal states from undue federal interference.
“If federal politicians were truly listening to the will of the electorate, they would move forward to enact these federal changes, which are strongly in line with voters’ sentiments. According to national polling data released today, 71 percent of voters — including majorities of Democrats, Independents, and Republicans — say that they “oppose the government enforcing federal laws against marijuana in states that have already legalized medical or recreational marijuana.” In short, undermining voters’ wishes and state laws in this regard not only defies common sense, it is also bad politics — particularly for an administration that is defining itself as populist in nature.”
Click here to email your member of Congress and urge them to support The Respect States’ Marijuana Laws Act.
Click here to email your member of Congress to insist that they join the newly formed Cannabis Caucus.
Record numbers of voters support regulating the marijuana market and oppose federal efforts to interfere or undermine state laws permitting the plant’s use or sale, according to nationwide polling data released today by Quinnipiac University.
Ninety-three percent of voters — including 96 percent of Democrats and 85 percent of Republicans — support “allowing adults to legally use marijuana for medical purposes,” the highest total ever reported in a national poll. Among those respondents older than 65 years of age, 92 percent endorsed legalizing medical marijuana.
Fifty-nine percent of voters similarly support making the adult use of marijuana legal in the United States. That total is in line with recent polling data compiled by Gallup in 2016 which reported that 60 percent of US adults support legalization — a historic high. Respondents who identified as Democrats (72 percent) were most likely to support legalization. Fifty-eight percent of Independents also expressed support, but only 35 percent of Republicans did so. Among the various age groups polled, only those over the age of 65 failed to express majority support for legalization.
Finally, 71 percent of respondents say that they “oppose the government enforcing federal laws against marijuana in states that have already legalized medical or recreational marijuana.” This percentage is the highest level of support ever reported with regard to limiting the federal government from interfering in states’ marijuana policies.
The rising support may provide a boost for pending federal legislation, HR 975: The Respect State Marijuana Laws Act, which prevents the federal government from criminally prosecuting individuals and/or businesses who are engaging in state-sanctioned activities specific to the possession, use, production, and distribution of marijuana. You can urge your members of Congress to support this act by clicking here.
The Quinnipiac University poll possesses a margin of error of +/- 2.7 percentage points.
The fact that 190 million Americans now live in states where marijuana has been legalized to some degree is raising a number of questions and issues about how to integrate the American workforce and marijuana consumers rights in regards to drug testing. With medical marijuana is legal in 29 states and recreational marijuana for adult use in 8 states and Washington DC, millions of responsible and otherwise law-abiding adults remain at risk of being excluded from the workforce due to a positive drug test — even where the use does not affect an individual’s job performance or has taken place days or weeks prior to the test.
NORML believes that this practice is discriminatory and defies common sense. As a result, a growing coalition of NORML Chapters in California, Oregon, Colorado and Washington have come together to advocate for necessary legislative and workplace reforms to protect responsible marijuana consumers.
NORML’s Workplace Drug Testing Coalition’s efforts will focus on these four areas:
- Reform workplace drug testing policies
- Expand employment opportunities for marijuana consumers
- Clarify the difference between detection technology and performance testing
- Highlight off-duty state law legal protections for employees
“Even though marijuana is legal and readily available in several states, consumers are being unfairly forced to choose between their job and consuming off the clock as a result of out-of-date employment practices,” said Kevin Mahmalji, National Outreach Coordinator for NORML. “That is why many NORML chapters active in legal states are now shifting their attention to protecting honest, hardworking marijuana consumers from these sort of antiquated, discriminatory workplace drug-testing practices, in particular the use of random suspicionless urine testing.”
Employer testing of applicants or employees for trace metabolites (inert waste-products) of past use of a legal substance makes no sense in the 21st century. This activity is particularly discriminatory in the case of marijuana where such metabolites may be detectable for weeks or even months after the consumer has ceased use.
With the 2017 Legislative Session underway, this issue is finally getting the attention it deserves. Legislation has already been introduced in Oregon and Washington, and is gaining traction in those states.
“Random suspicionless drug testing of applicants or employees for past marijuana use is not just unfair and discriminatory, it’s bad for business,” said attorney Judd Golden of Boulder, Colorado, a long-time NORML activist and Coalition spokesperson. The modern workforce includes countless qualified people like Brandon Coats of Colorado, a paraplegic medical marijuana patient who never was impaired on the job and had an unblemished work record. Brandon was fired from a Fortune 500 company after a random drug test, and lost his case in the Colorado Supreme Court in 2015. The Court unfortunately found Colorado’s lawful off-duty activities law that protects employees for legal activities on their own time didn’t apply to marijuana use.
California NORML is also expecting legislation to be introduced this session to address this issue. Ellen Komp, deputy director of California NORML said, “One of the most frequently asked questions we have been getting since Prop. 64 passed legalizing adult marijuana use in California last November is, ‘Am I now protected against drug testing on my job?’ Sadly in our state, not even medical marijuana patients are protected against job discrimination, and it’s a priority of Cal NORML to change that. We are hoping to get a bill introduced at the state level and are working with legislators, unions, and other reform groups to make that happen.”
NORML Chapters across the country are advocating on behalf of the rights of responsible marijuana consumers against discrimination in the workplace. “Our coalition was formed with the intention of not only educating legislators, but also with businesses in mind. It is important they know testing for marijuana is not mandatory, and that employers have testing options,” said Jordan Person, executive director for Denver NORML. The Denver chapter is currently working with companies that offer performance impairment testing of workers suspected of on-the-job impairment or use rather than unreliable bodily fluid testing to help provide options for employers.
For decades drug testing companies and others have pushed their agenda through a campaign of misinformation. Until now there has never been an organized effort to challenge the profit- driven ideology of those who seek to benefit from intrusive drug screening. Mounting evidence continues to prove there is no logical reason why adult marijuana consumers should be treated with any less respect, restricted more severely, and denied the same privileges we extend to responsible adults who enjoy a casual cocktail after a long day at the office.
For legal questions, please contact Coalition spokesperson Judd Golden at email@example.com. For other marijuana related questions or an interview, please contact Kevin Mahmalji at firstname.lastname@example.org.
Language in Question 1: the Marijuana Legalization Act, specific to the private possession and cultivation of marijuana by adults took effect today. It permits adults who are not participating in the state’s existing medical cannabis program to possess up to 2.5 ounces of marijuana and/or the harvest of up to six mature plants.
Public use of marijuana is a civil infraction punishable by a $100 fine.
Maine voters narrowly passed Question 1 on Election Day.
In response to Question 1, Maine lawmakers passed separate legislation, LD 88, permitting adults to possess up to five grams of marijuana concentrates. However, other provisions in the measure delay the implementation of retail marijuana sales until at least February 1, 2018. It also prohibits the possession of “edible retail marijuana products” until this date.
Alaska, California, Colorado, Massachusetts, Nevada, Oregon, and Washington have previously adopted voter-initiated laws legalizing the private consumption and/or sale of cannabis by adults. The District of Columbia also permits adults to legally possess and grow personal use quantities of marijuana in private residences.
The passage of medical marijuana legalization is associated with reduced traffic fatalities among younger drivers, according to data published online ahead of print in the American Journal of Public Health.
Investigators from Columbia University in New York and the University of California at Davis analyzed traffic fatality data from the years 1985 to 2014.
They reported that states with medical cannabis laws had lower overall traffic fatality rates compared to states where cannabis is illegal, and that there was an immediate decline in motor vehicle deaths following the establishment of a legal cannabis market – particularly among those under 44 years of age.
Authors concluded: “[O]n average, MMLs (medical marijuana laws) states had lower traffic fatality rates than non-MML states. …. MMLs are associated with reductions in traffic fatalities, particularly pronounced among those aged 25 to 44 years. … It is possible that this is related to lower alcohol-impaired driving behavior in MML-states.”
An abstract of the study, “US traffic fatalities, 1985-2014, and their relationship to medical marijuana laws,” appears online here.